Tessa Therapeutics Pte Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Tessa Therapeutics Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013402
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:シンガポール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tessa Therapeutics Pte Ltd (Tessa Therapeutics) is a clinical-stage biotechnology company that develops and commercializes cancer immunotherapies that redirect the body’s powerful anti-viral immune response to identify and exterminate cancer cells. The company provides products for various cancers including nasopharyngeal, gastric carcinoma, cervical, oropharyngeal, lung, head and neck cancer. It harnesses virus-specific T cell (VST) technology for the treatment of solid tumors. Tessa Therapeutics is also extending its VST platform to treat an array of solid tumors through combinatorial approaches with antibodies, chimeric antigen receptors, and oncolytic virus technologies. The company works in partnership with National Cancer Centre, Singapore; Baylor College of Medicine; and Agency for Science, Technology and Research. Tessa Therapeutics is headquartered in Singapore.

Tessa Therapeutics Pte Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Agreement 10
Tessa Therapeutics and Vyriad Enter into Agreement 11
Tessa Therapeutics Enters into Agreement with Institute of Molecular and Cell Biology 12
Tessa Therapeutics Enters into Co-Development Agreement with Baylor Medical College 13
National Cancer Centre Singapore and Tessa Therapeutics Expand Research Agreement 14
Licensing Agreements 15
Tessa Therapeutics Enters into Licensing Agreement with Baylor College of Medicine 15
Acquisition 16
Tessa Therapeutics Acquires Euchloe Bio 16
Tessa Therapeutics Pte Ltd – Key Competitors 17
Tessa Therapeutics Pte Ltd – Key Employees 18
Tessa Therapeutics Pte Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Jul 20, 2017: Tessa Therapeutics Appoints Ms. Jennifer Butler as Chief Commercial Officer 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tessa Therapeutics Pte Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Tessa Therapeutics Pte Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Agreement 10
Tessa Therapeutics and Vyriad Enter into Agreement 11
Tessa Therapeutics Enters into Agreement with Institute of Molecular and Cell Biology 12
Tessa Therapeutics Enters into Co-Development Agreement with Baylor Medical College 13
National Cancer Centre Singapore and Tessa Therapeutics Expand Research Agreement 14
Tessa Therapeutics Enters into Licensing Agreement with Baylor College of Medicine 15
Tessa Therapeutics Acquires Euchloe Bio 16
Tessa Therapeutics Pte Ltd, Key Competitors 17
Tessa Therapeutics Pte Ltd, Key Employees 18
Tessa Therapeutics Pte Ltd, Subsidiaries 19

★海外企業調査レポート[Tessa Therapeutics Pte Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • H. Lundbeck AS (LUN):企業の財務・戦略的SWOT分析
    H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Allinky Biopharma SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Allinky Biopharma SL (Allinky) is a developer of small molecules for the treatment of cancer and inflammatory diseases. The company offers research and development of basic and clinical sciences and discovery of novel therapies. Its therapeutic agents comprise active site drugs, target prote …
  • Hydro One Ltd (H):企業の財務・戦略的SWOT分析
    Hydro One Ltd (H) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nordex SE (NDX1):電力:M&Aディール及び事業提携情報
    Summary Nordex SE (Nordex) is an integrated supplier of onshore wind turbine systems. It develops, produces, services and markets wind power systems. The company develops and produces complete systems, including the control software and main core components, and offers related services. Nordex serve …
  • Sunstar Holding AG:戦略・SWOT・企業財務分析
    Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Lees Foods Ltd.:企業の戦略・SWOT・財務分析
    Lees Foods Ltd. - Strategy, SWOT and Corporate Finance Report Summary Lees Foods Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Northern Ireland Electricity Networks Ltd:企業の戦略的SWOT分析
    Northern Ireland Electricity Networks Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Scripps Health:企業の戦略的SWOT分析
    Scripps Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • DLF Ltd:企業の戦略・SWOT・財務分析
    DLF Ltd - Strategy, SWOT and Corporate Finance Report Summary DLF Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Bonus BioGroup Ltd (BONS):医療機器:M&Aディール及び事業提携情報
    Summary Bonus BioGroup Ltd (Bonus BioGroup), formerly Oceania advanced industries Ltd is a biotechnology company that supplies tissue-engineered viable bone grafts. The company operates in the field of tissue engineering and live bone transplantation. Its products include BonoFill injectable bone gr …
  • Enel SpA (ENEL):電力:M&Aディール及び事業提携情報
    Summary Enel SpA (Enel) is an integrated electricity and gas company that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on di …
  • MS&AD Insurance Group Holdings, Inc.:企業の戦略・SWOT・財務情報
    MS&AD Insurance Group Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary MS&AD Insurance Group Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • US Physical Therapy Inc (USPH):企業の財務・戦略的SWOT分析
    US Physical Therapy Inc (USPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Faron Pharmaceuticals Oy (FARN):製薬・医療:M&Aディール及び事業提携情報
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that conducts clinical stage drug discovery and development. The company's pipeline products focus on cute organ traumas, vascular damage and cancer immunotherapy. It offers Traumakine, that helps to prevent vascu …
  • Broadridge Financial Solutions Inc (BR):企業の財務・戦略的SWOT分析
    Broadridge Financial Solutions Inc (BR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Compuware Corp:企業の戦略・SWOT・財務情報
    Compuware Corp - Strategy, SWOT and Corporate Finance Report Summary Compuware Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Hotel Royal Limited:企業の戦略・SWOT・財務情報
    Hotel Royal Limited - Strategy, SWOT and Corporate Finance Report Summary Hotel Royal Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Baoye Group Company Limited:企業の戦略・SWOT・財務情報
    Baoye Group Company Limited - Strategy, SWOT and Corporate Finance Report Summary Baoye Group Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • China Resources Power Holdings Co Ltd:企業の発電所・SWOT分析2018
    China Resources Power Holdings Co Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • Johnson Electric Holdings Limited (179):企業の財務・戦略的SWOT分析
    Johnson Electric Holdings Limited (179) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆